Perrigo Rapped Over Solpadeine Claim in UK, While Cleared Of Wrongdoing In Spanish XLS Ad
Executive SummaryPerrigo has found itself in hot water with the UK's MHRA over claims made on the website of its Solpadeine pain-relief brand. Meanwhile, the company has been exonerated after complaints against a TV ad to promote its XLS weight-loss brand proved to be unfounded.
You may also be interested in...
Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).